Core Viewpoint - The medical beauty industry is experiencing a shift from supply scarcity to abundance, allowing institutions to negotiate better prices and providing more options for consumers [2][3][9]. Group 1: Market Dynamics - New Oxygen's "Miracle Youth" project has seen continuous sales growth for three months since its launch, despite pricing disputes with upstream suppliers [2]. - The price of "Miracle Youth" products is significantly lower than the manufacturer's suggested retail price, with some products priced at 60% less than the official price [2][5]. - The increase in the number of products available in the market has provided institutions with more choices, reducing reliance on single suppliers [3][9]. Group 2: Competitive Landscape - The market for "Miracle Youth" products, specifically the PLLA facial filler, has seen multiple companies approved for production, increasing competition [5]. - New Oxygen's pricing strategy has led to conflicts with suppliers, who are concerned about the disruption of established pricing structures [6]. - The number of approved products in the PLLA category is expected to grow, with 11 products already approved and nearly 20 more in the pipeline [9]. Group 3: Business Strategy - New Oxygen aims to leverage its scale by expanding its number of clinics and increasing treatment volumes, which enhances its negotiating power with suppliers [6][7]. - The company plans to open at least 35 new clinics by 2026, with a target of increasing the number of doctors and nursing staff significantly [7]. - Despite ongoing losses due to expansion, New Oxygen's strategy focuses on achieving profitability by optimizing operations and offering a wider range of products at different price points [11].

Core Viewpoint - New Oxygen Group is successfully transitioning from an online medical beauty platform to a chain of offline medical beauty clinics, with its flagship product, the Miracle Youth Needle, showing significant sales growth despite pricing disputes with upstream suppliers [2][5]. Group 1: Business Model and Pricing Strategy - New Oxygen's business model focuses on large-scale procurement and low-margin sales, allowing it to offer prices significantly below manufacturer guidance, such as 5,999 yuan for a product with a manufacturer price of 16,800 yuan [2][4]. - The company has expanded its clinic presence to 50 locations across 16 cities, leveraging its scale to negotiate better prices with suppliers [3][6]. - The Miracle Youth Needle series has seen treatment volumes exceed 8,600 by December 2025, a threefold increase since September [5]. Group 2: Market Dynamics and Supplier Relations - The medical beauty industry is shifting from a supply-scarce to a supply-abundant phase, providing institutions with more options and negotiating power against suppliers [3][8]. - New Oxygen's pricing strategy has led to tensions with suppliers, who are concerned about the disruption of established pricing structures [5][6]. - The company maintains that its low prices do not come at the expense of upstream profits, as it aims for mutually beneficial relationships with suppliers [6][9]. Group 3: Future Plans and Financial Goals - New Oxygen plans to open at least 35 new clinics in 2026, with an increase in medical staff to 500 doctors and 1,000 nursing personnel by the end of the year [7]. - The company aims to achieve overall profitability by 2026 through improved operational efficiency and a diversified product offering [9][10]. - Despite ongoing losses due to expansion, New Oxygen is focused on optimizing its business model to enhance gross margins while continuing to provide competitive pricing [9].